Navigation Links
Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st Annual Meeting of the American Society of Hematology
Date:11/12/2009

onsider past results to be an indication of our future performance. For a discussion of the risk factors and other factors that may affect our results, please see the Risk Factors section of our filings with the Securities and Exchange Commission, including our annual report on Form 10-K and quarterly reports on Form 10-Q. We do not intend to update any of the forward-looking statements after the date of this announcement to conform these statements to actual results, to changes in management's expectations or otherwise, except as may be required by law. We plan to provide a material update to this ongoing Phase I study in the form of this poster presentation.

About Pharmacyclics

Pharmacyclics® is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative small-molecule drugs for the treatment of immune mediated disease and cancer. The purpose of the company is to create a profitable business by generating income from products it develops, licenses and commercializes, either with one or several potential partners or alone as may best forward the economic interest of its stakeholders. The Company endeavors to create novel, patentable, differentiated products that have the potential to significantly improve the standard of care in the markets it serves. Presently, Pharmacyclics has four product candidates in clinical development and two product candidates in pre-clinical development. It is Pharmacyclics' business strategy to establish collaborations with large pharmaceutical and biotechnology companies for the purpose of generating present and future income in exchange for adding to their product pipelines. Pharmacyclics strives to generate collaborations that allow it to retain valuable territorial rights and simultaneously fast forward the clinical development and commercialization of its products. The Company is headquartered in Sunnyvale, California and is listed on NASDAQ under the symbol PCY
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
7. Pharmacyclics, Inc. Announces Closing of a Private Financing With the Principals of Pacific Biopharma Group, Ltd.
8. Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkins Lymphoma
9. Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier
10. Pharmacyclics to Present at Merriman Curhan Fords Investor Summit 2009
11. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... , May 1, 2015 Hitachi Chemical Diagnostics, ... States launch of the ExoComplete™ 96-Well Plate ... easy system for exosome collection to mRNA purification.  The ... Vesicles ("ISEV") Annual Meeting, April 23 – 26, 2015, ... are intended for research use only of molecular biology ...
(Date:5/1/2015)... May 1, 2015 Following yesterday,s release of Center ... here are five things you need to know: ... structure is unique among government programs. ... is different than other parts of Medicare and other government ... submit bids to offer prescription drug benefits to enrollees. ...
(Date:5/1/2015)... CAMBRIDGE, Mass. , May 1, 2015  Portal ... innovative drug delivery systems, announced today that Robert ... Hunter , Ph.D., University of Auckland Distinguished Professor have ... are thrilled to welcome two esteemed biotechnology leaders, Professor ... , to our team," said Dr. Patrick Anquetil ...
Breaking Medicine Technology:New Products for Exosome Isolation to mRNA Purification 25 Things to Know About the CMS Part D Data Release 25 Things to Know About the CMS Part D Data Release 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 2Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 3Portal Instruments Adds Two Esteemed Biotechnology Leaders to its Scientific Advisory Board 4
(Date:5/2/2015)... 2015 On Tuesday April 7th, the ... gathered to celebrate improvements in patient care. In 2014 ... (RVHP), had zero acquired ventilator associated infections, zero central ... ELCH was also recently named a Top Performer by ... ELCH credited the teamwork of staff from all departments ...
(Date:5/1/2015)... IDLife LLC, a health and wellness ... the addition of its newest partner and fitness celebrity, ... athlete, growing up in gymnastics and competitive diving, but ... a personal trainer and helping others achieve their fitness ... TV shows highlighting her stunning physique and unique training ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 The ... leading nonprofit authority on the use of health IT ... a key contributing resource to the United States Government ... of electronically readable cards in Medicare. The report, “ ... Providers ” was released to the public on Apr. ...
(Date:5/1/2015)... The fields of genetics and genomics, the ... genes with one another and the environment, is rapidly ... LabRoots, the premier producer of interactive virtual events for ... its annual conference spotlighting the recent advances in Genetics ... Genomics 2015 , a two-day event presented entirely online ...
(Date:5/1/2015)... May 01, 2015 The frozen yogurt ... the Hickory Crawdads (NC) and the Myrtle Beach Pellicans ... in-stadium concession locations and offer fans discounts at local ... the Hickory Community,” said Luke Shook, co-owner of the ... opportunity and we look forward to enjoying the games ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... Insurance,Holdings, Inc. (Nasdaq: EIHI ) ("EIHI," the "Company") ... $0.05 per share quarterly cash,dividend on its issued and ... shareholders of record at the close of business on,December ... Eastern Life and Health Insurance Company,("Eastern Life and Health"), ...
... 2 Clinical Trials,Dow AgroSciences CEO Discusses Future Opportunities with ... BioSciences, Inc.,(Nasdaq: SGMO ) announced that the company ... preview objectives for 2008 during its,annual Investor and Analyst ... Peribere, President and CEO of Dow AgroSciences will discuss ...
... IDEV ) today announced the Company will be ... 13, 2007 at 12:30 PM,Eastern Time. The conference is ... web cast live and may be accessed by visiting ... ., About Indevus, Indevus Pharmaceuticals, Inc. is ...
... ROCKVILLE, Md., Dec. 5 An array of ... and others,reduce medical errors was released today by ... 17 toolkits, developed by AHRQ-funded experts who specialize ... can be adapted,to most health care settings. The ...
... a more complicated medical case, what makes different ... patients" Researchers at UC Davis have identified several ... length of a patients medical appointment, and ultimately ... , In a new study, "Primary Care ...
... markers play a role, and the condition can be inherited ... News) -- A U.S. team has spotted nine genetic markers ... also found evidence that the condition can be inherited in ... parents. , "If a person inherits identical copies of these ...
Cached Medicine News:Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 2Health News:Eastern Insurance Holdings, Inc. Announces Quarterly Dividend 3Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 2Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 3Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 4Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 5Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 6Health News:Sangamo BioSciences Provides Update on Company's Accomplishments in 2007 and 2008 Objectives 7Health News:Indevus Pharmaceuticals To Present at RBC Capital Markets Conference 2Health News:Indevus Pharmaceuticals To Present at RBC Capital Markets Conference 3Health News:AHRQ Releases Toolkits to Help Providers and Patients Implement Safer Health Care Practices 2Health News:New UC Davis study finds physician style and HMO affiliation impact lengths of patient visit 2Health News:Genes Yield More Clues to Schizophrenia 2
... monitoring for intermediate care., ,The S/5 FM ... Datex-Ohmeda S/5 product line., ,The S/5 FM ... power to grow. The new Patient Side Module ... up to 12-lead ECG, NIBP, motion-tolerant SpO ...
... ,The Datex-Ohmeda S/5 Light Monitor is a ... and critical care areas, in emergency or medium-care ... part of the Datex-Ohmeda S/5 family, the S/5 ... and design shared by all S/5 monitoring products ...
... ,The S/5 Anesthesia Monitor (AM) is a ... solution for routine to the most demanding anesthesia ... you can choose the set of parameters that ... your needs evolve, the modularity of the S/5 ...
... Golden Standard in Metabolic Monitoring, ,The ... in a compact, easy-to-use bedside unit. It's ... a canopy and is equally suited to ... of all ages., ,The individual nutritional ...
Medicine Products: